Old Mission Capital’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,603
Closed -$370K 1415
2021
Q2
$370K Buy
+12,603
New +$393K 0.01% 716
2020
Q2
Sell
-15,890
Closed -$548K 670
2020
Q1
$548K Buy
15,890
+6,095
+62% +$212K 0.05% 207
2019
Q4
$325K Buy
+9,795
New +$293K 0.03% 239
2019
Q1
Sell
-17,466
Closed -$203K 371
2018
Q4
$203K Buy
+17,466
New +$229K 0.02% 266
2018
Q1
Sell
-15,802
Closed -$215K 567
2017
Q4
$215K Buy
+15,802
New +$248K 0.01% 343

Other funds holding ZEAL

Old Mission Capital's ZEAL Position: Q3 2021 in Review

Old Mission Capital sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2021, closing a stake of 12,603 shares — an estimated $370K sold.

Old Mission Capital first reported a position in ZEAL in Q4 2017 and held it in 5 quarters. The position peaked at $548K in Q1 2020. 14 funds tracked by Wall St. Rank hold ZEAL as of Q3 2021.

  • Old Mission Capital reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Old Mission Capital sold 12,603 Zealand Pharma A/S American Depositary Shares shares in Q3 2021, an estimated $370K.
  • Old Mission Capital first reported a position in Zealand Pharma A/S American Depositary Shares in Q4 2017 and held it in 5 quarters.
  • Old Mission Capital's Zealand Pharma A/S American Depositary Shares position peaked at $548K in Q1 2020.
  • 14 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2021.

Based on Old Mission Capital's 13F filing for Q3 2021, filed 12 Nov 2021.